Form 4 for AVTR Avantor, Inc.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-20 · accession 0001722482-22-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-20 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $34.00 | -3,072 | 128.2K | -2% | -$104.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-20 | F | D | 3,072 | $34.00 | 128,240 | D | — | — |